{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:48:27Z","timestamp":1790621307306,"version":"4.1.0"},"reference-count":89,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p><jats:bold>Objectives:\u00a0<\/jats:bold> To determine the clinical effectiveness of drugs with anticonvulsant properties for interventions in persons with bipolar disorder and to place these findings in the context of clinicians\u2019 practices and their implications for future research to more effectively manage bipolar disorders.<\/jats:p><jats:p><jats:bold>Methods:\u00a0<\/jats:bold> Major electronic databases were searched up to February 2009 for clinical trial data, both original studies and reviews, on drugs with anticonvulsant properties studied for bipolar disorders.<\/jats:p><jats:p><jats:bold>Results:\u00a0<\/jats:bold> Valproate, principally as divalproex, has strong evidence for effectiveness in mania, moderately strong evidence for benefits in prophylaxis of recovered states, and recent proof\u2010of\u2010concept evidence for benefits in bipolar depression. Lamotrigine has strong evidence for evidence for effectiveness in maintenance treatment of bipolar disorder, principally for benefits in depressive states. Lamotrigine has been established as ineffective in mania and has lacked efficacy in acute bipolar depression in most randomized trials. Carbamazepine has strong evidence for effectiveness in mania, but lacks adequate studies in other aspects of bipolar disorder treatment. Its adverse effect profile and pharmacokinetic interference with a wide range of drugs, including many employed in bipolar disorder, warrants limitation of use to patients who have responded inadequately to other regimens.<\/jats:p><jats:p><jats:bold>Conclusions:\u00a0<\/jats:bold> Three drugs, valproate, lamotrigine, and carbamazepine, have strong evidence\u2010based support for use in clinical states of bipolar disorder. Other anticonvulsant drugs investigated in bipolar disorder either have evidence of lack of benefits in bipolar disorder or have been inadequately studied to determine possible effectiveness.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2009.00708.x","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T15:16:04Z","timestamp":1243869364000},"page":"20-33","source":"Crossref","is-referenced-by-count":49,"title":["Anticonvulsants in bipolar disorders: current research and practice and future directions"],"prefix":"10.1111","volume":"11","author":[{"given":"Charles L","family":"Bowden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6]]},"reference":[{"key":"e_1_2_10_2_2","first-page":"707","article-title":"Action neuropsychotrope d\u2019un nouvel anti\u2010epileptique: le depamide","volume":"1","author":"Lambert PA","year":"1966","journal-title":"Ann Med Psychol"},{"key":"e_1_2_10_3_2","first-page":"173","article-title":"The use of carbamazepine (Tegretol) in the control of manic depressive psychosis and other manic, depressive states","volume":"13","author":"Takezaki H","year":"1971","journal-title":"Seishin Shinkeigaku Zasshi (Psychiatria et Neurologia Japonica)"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.2.185"},{"key":"e_1_2_10_5_2","first-page":"3","article-title":"History of the development of valproate for treatment of bipolar disorder","volume":"56","author":"Bowden CL","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2007.09.012"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.17.4.250"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0308"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0405"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00490.x"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00468.x"},{"key":"e_1_2_10_14_2","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen J","year":"1988"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1003"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00390-6"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145703003535"},{"key":"e_1_2_10_18_2","first-page":"31","article-title":"Growing placebo response rate: the problem in recent therapeutic trials?","volume":"33","author":"Uhlenhuth EH","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1263"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1210"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n1113"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3282fd827c"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000380"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200004000-00012"},{"key":"e_1_2_10_25_2","first-page":"142","article-title":"A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania","volume":"59","author":"McElroy SL","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200006000-00009"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.2.141"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.041301"},{"key":"e_1_2_10_29_2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/ajp.2006.163.7.1179","article-title":"A double\u2010blind, randomized, placebo\u2010controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents","volume":"163","author":"Wagner KD","year":"2008","journal-title":"Am J Psychiatry"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2006.00276.x"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200012000-00004"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2000.20305.x"},{"key":"e_1_2_10_33_2","first-page":"141","article-title":"Treatment of social phobia with gabapentin: a placebo\u2010controlled study","volume":"24","author":"Pande AC","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.104.007773"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.4161\/chan.2.1.6045"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363190-00009"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.3.463"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(02)00267-4"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.5.481"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta11390"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2007.08.014"},{"key":"e_1_2_10_42_2","first-page":"57","article-title":"Comparative study of valpromide versus lithium as prophylactic treatment in affective disorders","volume":"5","author":"Lambert PA","year":"1992","journal-title":"Nervure"},{"key":"e_1_2_10_43_2","first-page":"693","article-title":"Maintenance clinical trials in bipolar disorder: design implications of the divalproex\u2010lithium\u2010placebo study","volume":"33","author":"Bowden CL","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.4.337"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1080\/13651500500305622"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.11.2152"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.392"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0203"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0321"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n1106"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00013-X"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(03)00079-8"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427030-00002"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.7.1199"},{"key":"e_1_2_10_55_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S1092852900016187","article-title":"Open\u2010labeled, concomitant use of lamotrigine and other medications for bipolar disorder","volume":"13","author":"Bowden CL","year":"2008","journal-title":"CNS Spectr"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.3.10.1513"},{"key":"e_1_2_10_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199914050-00002"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0206"},{"key":"e_1_2_10_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00500.x"},{"key":"e_1_2_10_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(99)00024-3"},{"key":"e_1_2_10_61_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04152"},{"key":"e_1_2_10_62_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0703"},{"key":"e_1_2_10_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2004.09.009"},{"key":"e_1_2_10_64_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1203"},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300190"},{"key":"e_1_2_10_66_2","first-page":"155","volume-title":"Antiepileptic Drugs to Treat Psychiatric Disorders","author":"Kemp DE","year":"2008"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0206"},{"key":"e_1_2_10_68_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0512"},{"key":"e_1_2_10_69_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200008000-00011"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199908000-00010"},{"key":"e_1_2_10_71_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000264969.47087.5a"},{"key":"e_1_2_10_72_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0707"},{"key":"e_1_2_10_73_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.JGP.0000224657.37446.9b"},{"key":"e_1_2_10_74_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1107"},{"key":"e_1_2_10_75_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.01201.x"},{"key":"e_1_2_10_76_2","first-page":"534","article-title":"An exploratory open trial on safety and efficacy of the anticonvulsant retigabine in acute manic patients","volume":"26","author":"Amann B","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"e_1_2_10_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91154-0"},{"key":"e_1_2_10_78_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2003.00031.x"},{"key":"e_1_2_10_79_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.6.765"},{"key":"e_1_2_10_80_2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1017\/S1092852900015091","article-title":"Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series","volume":"11","author":"Redmond JR","year":"2006","journal-title":"CNS Spectr"},{"key":"e_1_2_10_81_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200306000-00016"},{"key":"e_1_2_10_82_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900028704"},{"key":"e_1_2_10_83_2","doi-asserted-by":"publisher","DOI":"10.3109\/9780849382666.021"},{"key":"e_1_2_10_84_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-19-07311.2003"},{"key":"e_1_2_10_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00361.x"},{"key":"e_1_2_10_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.08.027"},{"key":"e_1_2_10_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301671"},{"key":"e_1_2_10_88_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300764"},{"key":"e_1_2_10_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.06.036"},{"key":"e_1_2_10_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.05.084"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2009.00708.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2009.00708.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:38:04Z","timestamp":1694561884000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2009.00708.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":89,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1399-5618.2009.00708.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2009.00708.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}